Timing for Rechecking Iron Studies After Starting Supplementation

Initial Assessment at 4 Weeks

Check hemoglobin level at 4 weeks after starting oral iron to determine treatment effectiveness, as recommended by the Gut guideline 1, 2
Expected hemoglobin rise should be 1-2 g/dL within 4-8 weeks of starting therapy, according to the Praxis Medical Insights guideline 3

Recheck complete iron studies (hemoglobin, ferritin, and transferrin saturation) at 3 months to assess iron store replenishment, as recommended by the Gut and Praxis Medical Insights guidelines 1, 3, 2
Continue oral iron for a full 3 months after hemoglobin normalization to ensure adequate marrow iron store repletion, as recommended by the Gut and Praxis Medical Insights guidelines 1, 2
Stopping iron too early results in recurrence of iron deficiency in >50% of patients within 1 year, according to the Praxis Medical Insights guideline 3

Do not check ferritin levels within 4 weeks of IV iron administration, as ferritin becomes falsely elevated and unreliable during this period, as recommended by the Praxis Medical Insights guideline 3, 2, 4
For IV iron doses ≥1000 mg, wait 4-8 weeks before rechecking iron parameters for accurate assessment, according to the Praxis Medical Insights guideline 3, 4
For smaller IV iron doses (100-500 mg), wait at least 1-2 weeks before checking iron studies, as recommended by the Kidney International Supplements and Praxis Medical Insights guidelines 4, 5
Hemoglobin can be checked at 4 weeks after IV iron to assess response, according to the Praxis Medical Insights guideline 2

For CKD patients on erythropoietin-stimulating agents (ESA), monitor iron status (ferritin and transferrin saturation) every 1-3 months depending on clinical stability, as recommended by the Kidney International Supplements guideline 5, 6
Target ferritin >100-200 ng/mL and transferrin saturation >20% in CKD patients, according to the Kidney International Supplements and Praxis Medical Insights guidelines 4, 5

After achieving normal hemoglobin and iron stores, monitor hemoglobin and red cell indices every 3 months for the first year, then annually, as recommended by the Praxis Medical Insights guideline 3, 2
For patients with chronic conditions requiring ongoing iron, check iron status 1-2 times per year as part of routine follow-up, according to the Praxis Medical Insights guideline 3, 2
If hemoglobin or mean corpuscular volume (MCV) falls below normal during follow-up, resume iron supplementation, as recommended by the Praxis Medical Insights guideline 3

Checking ferritin too soon after IV iron (within 4 weeks) yields falsely elevated readings that do not reflect true iron stores, as recommended by the Praxis Medical Insights guideline 3, 4
Stopping oral iron when hemoglobin normalizes without continuing for an additional 3 months results in inadequate iron store repletion and early recurrence, according to the Gut and Praxis Medical Insights guidelines 1, 3

The European Crohn's and Colitis Organisation recommends monitoring for recurrent iron deficiency every 3 months for at least a year after correction, then between 6-12 months thereafter, in patients with inflammatory bowel disease 7, 8
The European Crohn's and Colitis Organisation suggests re-treating with IV iron when serum ferritin drops below 100 μg/L or hemoglobin falls below 12 g/dL (women) or 13 g/dL (men) in patients with inflammatory bowel disease 7, 8
The Kidney International guideline recommends evaluating iron status (TSAT and ferritin) at least every 3 months during ESA therapy in patients with chronic kidney disease 9
The Kidney International guideline suggests testing iron status more frequently when initiating or increasing ESA dose, when there is blood loss, or when monitoring response after IV iron in patients with chronic kidney disease 9

The National Kidney Foundation recommends monitoring iron status (ferritin and transferrin saturation) at least every 3 months during erythropoietin-stimulating agent (ESA) therapy in patients with chronic kidney disease (CKD), with more frequent testing when initiating or increasing ESA dose, or when monitoring response after IV iron 10, 11
The European Crohn's and Colitis Organisation suggests monitoring for recurrent iron deficiency every 3 months for at least a year after correction, then between 6-12 months thereafter in patients with inflammatory bowel disease (IBD), and re-treating with IV iron when serum ferritin drops below 100 μg/L or hemoglobin falls below 12 g/dL (women) or 13 g/dL (men) 12